论文部分内容阅读
目的观察沐舒坦雾化吸入在新生儿肺炎治疗中的临床效果。方法随机抽取天津市宝坻区妇产医院于2016年6月-2017年2月收治的62例肺炎患儿作为研究对象,按照肺炎患儿家属的治疗意愿分为对照组和观察组各31例,在对症治疗的基础上,对照组给予常规治疗,观察组给予沐舒坦雾化吸入治疗,观察两组肺炎患儿的疗效和不良反应发生率。结果观察组肺炎患儿的治疗总有效率为100.00%,显著高于对照组的87.10%,差异有统计学意义(P<0.05)。观察组肺炎患儿的腹泻发生率为0.00%、皮疹发生率为3.23%、呕吐发生率为0.00%,略低于对照组腹泻发生率的3.23%、皮疹发生率的6.45%、呕吐发生率的3.23%,差异均无统计学意义(P>0.05)。结论沐舒坦雾化吸入在新生儿肺炎治疗中的疗效好,不良反应发生率低,可在临床治疗中推广应用。
Objective To observe the clinical effect of mucosolvan inhalation in the treatment of neonatal pneumonia. Methods Totally 62 children with pneumonia admitted in Maternal and Child Hospital of Baodi District of Tianjin from June 2016 to February 2017 were randomly divided into control group and observation group according to the treatment intention of children with pneumonia. On the basis of symptomatic treatment, the control group was given routine treatment, and the observation group was treated with mucosolvan inhalation. The curative effect and incidence of adverse reactions in both groups were observed. Results The total effective rate of treatment in children with pneumonia was 100.00% in the observation group, which was significantly higher than that in the control group (87.10%), the difference was statistically significant (P <0.05). The incidence of diarrhea in children with pneumonia in the observation group was 0.00%, the incidence of rash was 3.23%, the incidence of vomiting was 0.00%, slightly lower than that of the control group (3.23%), the incidence of rash was 6.45%, the incidence of vomiting 3.23%, the difference was not statistically significant (P> 0.05). Conclusion Mucosolvan inhalation is effective in the treatment of neonatal pneumonia, and the incidence of adverse reactions is low, so it can be widely used in clinical treatment.